ANGIOMAX Side Effects

7026986-7 | Anaphylactoid Reaction, Bradycardia, Bronchospasm, Shock, Urticaria
on Sep 16, 2010 Male patient from FRANCE , 47 years of age, was treated with Angiomax (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactoid reaction, bradycardia, bronchospasm, shock, urticaria. Angiomax dosage: 10 Ml, Bolus, Intravenous. During the same period patient was treated with VISIPAQUE (60 Ml) (View Visipaque Review and Visipaque Label ), MIDAZOLAM HCL (2 Mg, Qd, Intravenous) (View Midazolam Hcl Review and Midazolam Hcl Label ), PLAVIX (CLOPIDODGREL SULFATE) (View Plavix (clopidodgrel Sulfate) Review and Plavix (clopidodgrel Sulfate) Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), HEPARIN (View Heparin Review and Heparin Label ).

7023484-1 | Cardiac Arrest, Graft Thrombosis, Occult Blood Positive, Unresponsive To Stimuli, Ventricular Fibrillation, Ventricular Tachycardia
Patient was taking Angiomax (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), graft thrombosis, occult blood positive, unresponsive to stimuli, ventricular fibrillation, ventricular tachycardia on Sep 21, 2010 from UNITED STATES Additional patient health information: Male patient , 89 years of age, weighting 203.9 lb, was diagnosed with percutaneous coronary intervention and. Angiomax dosage: Bolus, Intravenous. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), FLOMAX (MORNIFLUMATE) (View Flomax (morniflumate) Review and Flomax (morniflumate) Label ), LECITHIN (LECITHIN) (View Lecithin (lecithin) Review and Lecithin (lecithin) Label ), POTASSIUM GLUCONATE (POTASSIUM GLUCONATE) TABLET (View Potassium Gluconate (potassium Gluconate) Tablet Review and Potassium Gluconate (potassium Gluconate) Tablet Label ), MAGNESIUM (MAGNESIUM) (View Magnesium (magnesium) Review and Magnesium (magnesium) Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), FLAXSEED OIL (LINUM USITATISSIMUM SEED OIL) (View Flaxseed Oil (linum Usitatissimum Seed Oil) Review and Flaxseed Oil (linum Usitatissimum Seed Oil) Label ).

6984746-7 | Off Label Use, Thrombosis
Adverse event was reported on Aug 30, 2010 by a Male patient taking Angiomax (View Usage) (Dosage: 2 Mg/kg, Intravenous; 2.5 Mg/kg/hr Infusion) was diagnosed with cardiopulmonary bypass and. Location: UNITED STATES , 51 years of age, weighting 134.5 lb, After Angiomax was administered, patient had the following side effects: off label use, thrombosis. During the same period patient was treated with HYDRALAZINE HCL (HYDRALAZINE HCL) (View Hydralazine Hcl (hydralazine Hcl) Review and Hydralazine Hcl (hydralazine Hcl) Label ), LISINOPRIL (LISINOPRIL DIHYDRATE) (View Lisinopril (lisinopril Dihydrate) Review and Lisinopril (lisinopril Dihydrate) Label ), FUROSEMIDE (FUROSEMIDE SODIUM) (View Furosemide (furosemide Sodium) Review and Furosemide (furosemide Sodium) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), AMINOCAPROIC ACID (View Aminocaproic Acid Review and Aminocaproic Acid Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6944899-3 | Activated Partial Thromboplastin Time Prolonged, Acute Myocardial Infarction, Gastric Ulcer Haemorrhage, Gastrointestinal Haemorrhage, Haemoglobin Decreased, Proctitis Haemorrhagic, Stress, Ventricular Hypokinesia
on Aug 10, 2010 Female patient from GERMANY , 80 years of age, weighting 143.3 lb, was diagnosed with arteriogram coronary, coronary artery disease (What is coronary artery disease?), acute myocardial infarction, percutaneous coronary intervention, atrial fibrillation (What is atrial fibrillation?) and was treated with Angiomax (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, acute myocardial infarction, gastric ulcer haemorrhage, gastrointestinal haemorrhage, haemoglobin decreased, proctitis haemorrhagic, stress (What is stress?), ventricular hypokinesia. Angiomax dosage: See Image. During the same period patient was treated with ASPIRIN (100 Mg, Qd (am), Oral) (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (600 Mg, Single, Oral; 75 Mg, Qd (am), Oral) (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (1000 Mg, Units/hr, Intravenous) (View Heparin Review and Heparin Label ), FRAXIPARIN (NADROPARIN CALCIUM) (0.40 Units, Qd) (View Fraxiparin (nadroparin Calcium) Review and Fraxiparin (nadroparin Calcium) Label ), MARCUMAR (Inr Related Regimen, Oral) (View Marcumar Review and Marcumar Label ). Patient was hospitalized.


6936938-0 | Mallory-weiss Syndrome
on Aug 05, 2010 Female patient from FRANCE , 81 years of age, weighting 121.3 lb, was treated with Angiomax (View Usage). Patient had the following side effects: mallory-weiss syndrome. Angiomax dosage: 8.3 Ml, Bolus, Intravenous, 19.3 Ml, Intravenous. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6924449-8 | Activated Partial Thromboplastin Time Prolonged, Acute Myocardial Infarction, Gastric Ulcer, Haemoglobin Decreased, Proctitis Haemorrhagic
Patient was taking Angiomax (View Usage). After Angiomax was administered, patient had the following side effects: activated partial thromboplastin time prolonged, acute myocardial infarction, gastric ulcer, haemoglobin decreased, proctitis haemorrhagic on Jul 28, 2010 from GERMANY Additional patient health information: Female patient , 80 years of age, weighting 143.3 lb, was diagnosed with arteriogram coronary, coronary artery disease (What is coronary artery disease?), acute myocardial infarction, percutaneous coronary intervention and. Angiomax dosage: 6.50 Mg, Bolus, Intravenous 16.5 Mg, Intravenous 33.0 Mg, Bolus, Intravenous 115.50 Mg, Intravenous. During the same period patient was treated with ASPIRIN (100 Mg, Qd (am), Oral) (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (600 Mg, Single, Oral 75 Mg, Qd (am), Oral) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6920303-6 | Coagulopathy, Haemorrhage, Iatrogenic Injury, Off Label Use
Adverse event was reported on Jul 27, 2010 by a Female patient taking Angiomax (View Usage) (Dosage: ) was diagnosed with heart valve replacement and. Location: UNITED STATES , 57 years of age, Patient experienced the following unwanted or unexpected effects: coagulopathy, haemorrhage, iatrogenic injury, off label use. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ).

6907302-5 | Acute Respiratory Failure, Blood Pressure Diastolic Decreased, Blood Pressure Systolic Increased, Cerebral Artery Embolism, Hypotension, Hypoxic-ischaemic Encephalopathy, Ischaemic Cerebral Infarction, Multi-organ Failure, Myocardial Infarction
on Jul 20, 2010 Female patient from UNITED STATES , 80 years of age, was diagnosed with catheterisation cardiac and was treated with Angiomax (View Usage). Patient had the following side effects: acute respiratory failure, blood pressure diastolic decreased, blood pressure systolic increased, cerebral artery embolism, hypotension, hypoxic-ischaemic encephalopathy, ischaemic cerebral infarction, multi-organ failure, myocardial infarction. Angiomax dosage: 5 Ml, Bolus, Intravenous, 95.3 Ml, Hr, Intravenous. During the same period patient was treated with HEPARIN (800 Iu, Hr With An Aptt Goal Of 50-67 Seconds, Iv Drip) (View Heparin Review and Heparin Label ), SEROQUEL (View Seroquel Review and Seroquel Label ). Patient was hospitalized.

6906251-6 | Mallory-weiss Syndrome
on Jul 20, 2010 Female patient from FRANCE , 81 years of age, weighting 121.3 lb, was treated with Angiomax (View Usage). After Angiomax was administered, patient had the following side effects: mallory-weiss syndrome. Angiomax dosage: 8.3 Ml, Bolus, Intravenous; 19.3 Ml, Intravenous. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6847799-2 | Coagulopathy, Haemorrhage, Off Label Use, Post Procedural Complication, Post Procedural Haemorrhage
Patient was taking Angiomax (View Usage). Patient experienced the following unwanted or unexpected effects: coagulopathy, haemorrhage, off label use, post procedural complication, post procedural haemorrhage on Jun 29, 2010 from UNITED STATES Additional patient health information: Female patient , 57 years of age, was diagnosed with coronary artery bypass (What is coronary artery bypass?) and. Angiomax dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ).

6831894-8 | Acute Myocardial Infarction, Electrocardiogram T Wave Inversion, Gastric Ulcer, Haemoglobin Decreased, Proctitis Haemorrhagic
Adverse event was reported on Jun 22, 2010 by a Female patient taking Angiomax (View Usage) (Dosage: 6.50 Mg, Bolus, Intravenous 16.5 Mg, Intravenous 33.0 Mg, Bolus, Intravenous 115.50 Mg, Intravenous) was diagnosed with arteriogram coronary, coronary artery disease (What is coronary artery disease?), acute myocardial infarction, atrial fibrillation (What is atrial fibrillation?) and. Location: GERMANY , 80 years of age, weighting 143.3 lb, Patient had the following side effects: acute myocardial infarction, electrocardiogram t wave inversion, gastric ulcer, haemoglobin decreased, proctitis haemorrhagic. During the same period patient was treated with ASPIRIN (100 Mg, Qd (am),oral) (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (600 Mg, Single, Oral 75 Mg, Qd (am), Oral) (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (1000 Mg, Units/hr, Intravenous) (View Heparin Review and Heparin Label ), FRAXIPARIN (NADROPARIN CALCIUM) (0.40 Units, Qd) (View Fraxiparin (nadroparin Calcium) Review and Fraxiparin (nadroparin Calcium) Label ). Patient was hospitalized.

6818819-6 | Vascular Pseudoaneurysm
on Jun 01, 2010 Male patient from GERMANY , 66 years of age, weighting 176.4 lb, was diagnosed with percutaneous coronary intervention and was treated with Angiomax (View Usage). After Angiomax was administered, patient had the following side effects: vascular pseudoaneurysm. Angiomax dosage: 12 Ml Bolus, Iv Bolus; 28 Ml, Hr, Intravenous; 4 Ml, Hr, Intravenous. During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), DIGITOXIN INJ (View Digitoxin Inj Review and Digitoxin Inj Label ), EBRANTIL (URAPIDIL) (View Ebrantil (urapidil) Review and Ebrantil (urapidil) Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), EPLERENONE (EPLERENONE) (View Eplerenone (eplerenone) Review and Eplerenone (eplerenone) Label ). Patient was hospitalized.

6816287-1 | Acute Myocardial Infarction, Bradycardia, Feeling Hot, Flushing, Lethargy, Sinus Tachycardia, Unresponsive To Stimuli, Ventricular Fibrillation
on May 05, 2010 Female patient from UNITED STATES , 62 years of age, weighting 213.8 lb, was diagnosed with percutaneous coronary intervention, ultrasound doppler and was treated with Angiomax (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, bradycardia, feeling hot, flushing, lethargy, sinus tachycardia, unresponsive to stimuli, ventricular fibrillation. Angiomax dosage: 14.85 Ml, Bolus, Intravenous; 1.75 Mg/kg, Hr. During the same period patient was treated with CONTRAST MEDIA () (110 Ml, Single) (View Contrast Media () Review and Contrast Media () Label ), NITROGLYCERIN (NITROGLYCERIN HCL) (View Nitroglycerin (nitroglycerin Hcl) Review and Nitroglycerin (nitroglycerin Hcl) Label ), VERSED (View Versed Review and Versed Label ), PLAVIX (View Plavix Review and Plavix Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ). Patient was hospitalized.

6816285-8 | Acute Respiratory Failure, Anoxic Encephalopathy, Cardiac Procedure Complication, Cerebral Artery Embolism, Haematoma, Hypotension, Ischaemic Cerebral Infarction, Multi-organ Failure
Patient was taking Angiomax (View Usage). Patient had the following side effects: acute respiratory failure, anoxic encephalopathy, cardiac procedure complication, cerebral artery embolism, haematoma, hypotension, ischaemic cerebral infarction, multi-organ failure on Jun 16, 2010 from UNITED STATES Additional patient health information: Female patient , 80 years of age, was diagnosed with catheterisation cardiac and. Angiomax dosage: 5 Ml, Bolus, Intravenous; 95.3 Ml, Hr, Intravenous. During the same period patient was treated with HEPARIN (800 Iu, Hr With An Aptt Goal Of 50-67 Seconds, Iv Drip; 800 Iu, Hr) (View Heparin Review and Heparin Label ), SEROQUEL (View Seroquel Review and Seroquel Label ). Patient was hospitalized.

6796358-9 | Coagulation Time Abnormal, Coagulopathy, Haemorrhage, Thrombosis
Adverse event was reported on Jun 07, 2010 by a Female patient taking Angiomax (View Usage) (Dosage: ) . Location: UNITED STATES , 34 years of age, After Angiomax was administered, patient had the following side effects: coagulation time abnormal, coagulopathy, haemorrhage, thrombosis.

6784120-2 | Angina Pectoris, Cardiac Function Test Abnormal, Ejection Fraction Decreased, Electrocardiogram St Segment Elevation, Thrombosis In Device, Ventricular Fibrillation
on Jun 04, 2010 Male patient from FRANCE , 78 years of age, was diagnosed with percutaneous coronary intervention and was treated with Angiomax (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, cardiac function test abnormal, ejection fraction decreased, electrocardiogram st segment elevation, thrombosis in device, ventricular fibrillation. Angiomax dosage: Intravenous; Perfusion Dose, Intravenous.

6765974-2 | Anuria, Arterial Injury, Compartment Syndrome, Gastritis Erosive, Gastrooesophageal Reflux Disease, Haematoma, Inflammation, Rhabdomyolysis, Skin Necrosis
on May 25, 2010 Male patient from FRANCE , 74 years of age, was diagnosed with coronary angioplasty, percutaneous coronary intervention and was treated with Angiomax (View Usage). Patient had the following side effects: anuria, arterial injury, compartment syndrome, gastritis erosive, gastrooesophageal reflux disease, haematoma, inflammation, rhabdomyolysis, skin necrosis. Angiomax dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), PLAVIX (View Plavix Review and Plavix Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), DIFFU K (View Diffu-k Review and Diffu-k Label ). Patient was hospitalized.

6760688-7 | Coagulation Time Shortened
Patient was taking Angiomax (View Usage). After Angiomax was administered, patient had the following side effects: coagulation time shortened on Jun 07, 2010 from UNITED STATES Additional patient health information: Female patient , 44 years of age, weighting 226.0 lb, was diagnosed with percutaneous coronary intervention and. Angiomax dosage: 80 Mg Once Iv Bolus, 185 Mg/hour Iv Drip.

6756161-2 | Incorrect Dose Administered
Adverse event was reported on Jun 03, 2010 by a Male patient taking Angiomax (View Usage) (Dosage: 19.5 Ml, Bolus, Intravenous) was diagnosed with percutaneous coronary intervention and. Location: UNITED STATES , 53 years of age, weighting 290.5 lb, Patient experienced the following unwanted or unexpected effects: incorrect dose administered. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (ACETULSALLCYCLIC ACID) (View Aspirin (acetulsallcyclic Acid) Review and Aspirin (acetulsallcyclic Acid) Label ).

6754999-9 | Intracardiac Thrombus, Retroperitoneal Haematoma
on May 19, 2010 Female patient from UNITED STATES , 88 years of age, was diagnosed with percutaneous coronary intervention and was treated with Angiomax (View Usage). Patient had the following side effects: intracardiac thrombus, retroperitoneal haematoma. Angiomax dosage: 0.75 Mg/kg, Bolus, 1.75 Mg/kg, Hr, Intravenous. During the same period patient was treated with UNFRACTIONATED HEPARIN (HEPARIN) (View Unfractionated Heparin (heparin) Review and Unfractionated Heparin (heparin) Label ).

6745182-1 | Cardiac Output Decreased, Cardiac Tamponade, Cardio-respiratory Arrest, Cardiogenic Shock, Enterococcal Infection, Mediastinitis, Peripheral Ischaemia, Post Procedural Haemorrhage, Thrombosis
on May 11, 2010 Female patient from UNITED STATES , 56 years of age, was diagnosed with intra-aortic balloon placement, thrombosis and was treated with Angiomax (View Usage). After Angiomax was administered, patient had the following side effects: cardiac output decreased, cardiac tamponade, cardio-respiratory arrest, cardiogenic shock, enterococcal infection, mediastinitis, peripheral ischaemia, post procedural haemorrhage, thrombosis. Angiomax dosage: Intravenous. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), HEPARIN (View Heparin Review and Heparin Label ).

6734610-3 | Angina Unstable, Chest Discomfort, Coagulation Time Prolonged, Dyspnoea, In-stent Coronary Artery Restenosis, No Therapeutic Response
Patient was taking Angiomax (View Usage). Patient experienced the following unwanted or unexpected effects: angina unstable, chest discomfort, coagulation time prolonged, dyspnoea, in-stent coronary artery restenosis, no therapeutic response on May 03, 2010 from UNITED STATES Additional patient health information: Male patient , 58 years of age, weighting 220.5 lb, . Angiomax dosage: 15 Ml, Bolus, Intravenous; 1.75 Mg/kg, Hr, Intravenous; 35 Ml, Hr, Intravenous. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), INTEGRILIN (View Integrilin Review and Integrilin Label ). Patient was hospitalized.

6734609-7 | Acute Myocardial Infarction, Angina Unstable, Blood Creatine Phosphokinase Increased, Coagulation Time Prolonged, Thrombosis In Device
Adverse event was reported on May 03, 2010 by a Male patient taking Angiomax (View Usage) (Dosage: 13.5 Ml, Bolus, Intravenous; 31.5 Ml, Hr, Intravenous) . Location: UNITED STATES , 66 years of age, weighting 200.6 lb, Patient had the following side effects: acute myocardial infarction, angina unstable, blood creatine phosphokinase increased, coagulation time prolonged, thrombosis in device. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), INTEGRILIN (View Integrilin Review and Integrilin Label ), MORPHINE SULFATE INJ (View Morphine Sulfate Inj Review and Morphine Sulfate Inj Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.

6719285-1 | Angina Unstable, Chest Discomfort, Dyspnoea, In-stent Coronary Artery Restenosis, Thrombosis In Device
on Apr 23, 2010 Female patient from UNITED STATES , 58 years of age, weighting 220.5 lb, was treated with Angiomax (View Usage). After Angiomax was administered, patient had the following side effects: angina unstable, chest discomfort, dyspnoea, in-stent coronary artery restenosis, thrombosis in device. Angiomax dosage: 0.75 Mg/kg, Bolus, Intravenous; 1.75 Mg/kg, Hr, Intravenous. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ABICIXIMAB (ABICIXIMAB) (View Abiciximab (abiciximab) Review and Abiciximab (abiciximab) Label ). Patient was hospitalized.

6719271-1 | Acute Myocardial Infarction, Angina Unstable, Thrombosis In Device
on Apr 23, 2010 Male patient from UNITED STATES , 66 years of age, weighting 200.6 lb, was treated with Angiomax (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, angina unstable, thrombosis in device. Angiomax dosage: 0.75 Mg/kg, Bolus, Intravenous; 1.75 Mg/kg, Hr, Intravenous. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), EPTIFIBATIDE (EPTIFIBATIDE) (View Eptifibatide (eptifibatide) Review and Eptifibatide (eptifibatide) Label ). Patient was hospitalized.

6719269-3 | Angina Unstable, Thrombosis In Device
Patient was taking Angiomax (View Usage). Patient had the following side effects: angina unstable, thrombosis in device on Apr 23, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, weighting 189.6 lb, . Angiomax dosage: See Image. During the same period patient was treated with ASPIRIN (ACELUSALICYLIC ACID) (View Aspirin (acelusalicylic Acid) Review and Aspirin (acelusalicylic Acid) Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6719264-4 | Angina Unstable, Chest Discomfort, Coagulation Time Prolonged, Coronary Artery Occlusion, Dyspnoea, Overdose
Adverse event was reported on Apr 23, 2010 by a Male patient taking Angiomax (View Usage) (Dosage: See Image) . Location: UNITED STATES , 75 years of age, weighting 185.2 lb, After Angiomax was administered, patient had the following side effects: angina unstable, chest discomfort, coagulation time prolonged, coronary artery occlusion, dyspnoea, overdose. During the same period patient was treated with ASPIRIN (ACETLYSALICYLIAC ACID) (View Aspirin (acetlysalicyliac Acid) Review and Aspirin (acetlysalicyliac Acid) Label ), PLAVIX (View Plavix Review and Plavix Label ), REOPRO (ABCIXIMAB) (View Reopro (abciximab) Review and Reopro (abciximab) Label ). Patient was hospitalized.

6672628-X | Anaphylactic Reaction, Cardio-respiratory Arrest, Pruritus, Throat Tightness
on Jan 11, 2010 Male patient from UNITED STATES , 83 years of age, weighting 151.9 lb, was diagnosed with percutaneous coronary intervention and was treated with Angiomax (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, cardio-respiratory arrest, pruritus, throat tightness. Angiomax dosage: 10.1 Ml, Intravenous; 24.5 Ml, Hr, Intravenous. During the same period patient was treated with OMNIPAQUE 350 (200 Ml, Intravenous) (View Omnipaque 350 Review and Omnipaque 350 Label ), PERCOCET (View Percocet Review and Percocet Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), COREG (View Coreg Review and Coreg Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ).

6671994-9 | Activated Partial Thromboplastin Time Prolonged, Gastrointestinal Haemorrhage, Haemodynamic Instability, Haemoglobin Decreased, Platelet Count Increased
on Mar 18, 2010 Male patient from UNITED STATES , 81 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Angiomax (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, gastrointestinal haemorrhage, haemodynamic instability, haemoglobin decreased, platelet count increased. Angiomax dosage: 0.15 Mg/kg, Hr, Intravenous, 0.15 Mg/kg, Hr, Intravenous. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ALBUTEROL (SALBUTAMOL SULFATE) (View Albuterol (salbutamol Sulfate) Review and Albuterol (salbutamol Sulfate) Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), DOCUSATE SODIUM (DOCUSATE SODIUM) (View Docusate Sodium (docusate Sodium) Review and Docusate Sodium (docusate Sodium) Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ).

6610283-5 | Coagulation Time Abnormal
Patient was taking Angiomax (View Usage). After Angiomax was administered, patient had the following side effects: coagulation time abnormal on Sep 30, 2009 from UNITED STATES Additional patient health information: Female patient , 95 years of age, . Angiomax dosage: Renal Dose, Intravenous.

6610277-X | Blood Pressure Increased, Haemorrhage Intracranial, Headache, Unresponsive To Stimuli
Adverse event was reported on Sep 10, 2009 by a Female patient taking Angiomax (View Usage) (Dosage: 0.75 Mg/kg, Bolus, Intravenous : 1.75 Mg/kg, Hr, Intravenous) was diagnosed with percutaneous coronary intervention and. Location: UNITED STATES , 73 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure increased, haemorrhage intracranial, headache (What is headache?), unresponsive to stimuli. During the same period patient was treated with PLAVIX (600 Mg, Oral) (View Plavix Review and Plavix Label ), BENADRYL (50 Mg, Single, Intravenous) (View Benadryl Review and Benadryl Label ), PEPCID (20 Mg, Single, Intravenous) (View Pepcid Review and Pepcid Label ), METHYLPREDNISOLONE (125 Mg, Single, Intravenous) (View Methylprednisolone Review and Methylprednisolone Label ).

6610238-0 | Coagulation Time Abnormal, Thrombosis In Device
on Aug 07, 2009 Male patient from UNITED STATES , 62 years of age, was diagnosed with percutaneous coronary intervention and was treated with Angiomax (View Usage). Patient had the following side effects: coagulation time abnormal, thrombosis in device. Angiomax dosage: 19 Ml, Bolus, Intravenous : 44 Ml/hr, Intravenous. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), INTEGRILIN (View Integrilin Review and Integrilin Label ).

6610213-6 | Blood Pressure Decreased, Retroperitoneal Haemorrhage
on Jul 06, 2009 Female patient from UNITED STATES , 69 years of age, was diagnosed with percutaneous coronary intervention and was treated with Angiomax (View Usage). After Angiomax was administered, patient had the following side effects: blood pressure decreased, retroperitoneal haemorrhage. Angiomax dosage: Intravenous. During the same period patient was treated with PLAVIX (Oral) (View Plavix Review and Plavix Label ), LIPITOR (View Lipitor Review and Lipitor Label ), INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ), NEXIUM (View Nexium Review and Nexium Label ), METOPROLOL (METOPROLOL) (View Metoprolol (metoprolol) Review and Metoprolol (metoprolol) Label ), PRINIVIL (View Prinivil Review and Prinivil Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), SORBITOL (SORBITOL) (View Sorbitol (sorbitol) Review and Sorbitol (sorbitol) Label ). Patient was hospitalized.

6610194-5 | Operative Haemorrhage
Patient was taking Angiomax (View Usage). Patient experienced the following unwanted or unexpected effects: operative haemorrhage on May 18, 2009 from UNITED STATES Additional patient health information: Male patient , 73 years of age, weighting 200.0 lb, was diagnosed with off label use, venous occlusion and. Angiomax dosage: 0.75 Mg/kg, Bolus, Intravenous, 1.75 Mg/kg, Hr, Intraven.

6610187-8 | Gastric Haemorrhage, Haematocrit Decreased, Haemoglobin Decreased, Hypotension
Adverse event was reported on Apr 16, 2009 by a Male patient taking Angiomax (View Usage) (Dosage: 0.75 Mg/kg, Bolus, Intravenous; 1.75 Mg/kg, Hr, Intravenous) was diagnosed with stent placement and. Location: UNITED STATES , 72 years of age, Patient had the following side effects: gastric haemorrhage, haematocrit decreased, haemoglobin decreased, hypotension. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ).

6610170-2 | Chest Pain, Thrombosis In Device
on Apr 20, 2009 Male patient from UNITED STATES , 63 years of age, was diagnosed with percutaneous coronary intervention and was treated with Angiomax (View Usage). After Angiomax was administered, patient had the following side effects: chest pain (What is chest pain?), thrombosis in device. Angiomax dosage: . During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ), PLAVIX (View Plavix Review and Plavix Label ).

6610168-4 | Chest Pain, Thrombosis In Device
on Apr 20, 2009 Male patient from UNITED STATES , 72 years of age, was diagnosed with percutaneous coronary intervention and was treated with Angiomax (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), thrombosis in device. Angiomax dosage: . During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ), PLAVIX (View Plavix Review and Plavix Label ).

6610148-9 | Coagulation Time Abnormal, Haemorrhage
Patient was taking Angiomax (View Usage). Patient had the following side effects: coagulation time abnormal, haemorrhage on Mar 22, 2009 from UNITED STATES Additional patient health information: Male patient , 78 years of age, was diagnosed with coronary artery bypass (What is coronary artery bypass?) and. Angiomax dosage: Intravenous.

6610127-1 | Coagulation Time Abnormal, Thrombosis
Adverse event was reported on May 13, 2009 by a Male patient taking Angiomax (View Usage) (Dosage: 14.3 Ml, Bolus, Intravenous : 33.3 Ml, Hr) was diagnosed with percutaneous coronary intervention and. Location: UNITED STATES , 64 years of age, weighting 211.4 lb, After Angiomax was administered, patient had the following side effects: coagulation time abnormal, thrombosis. During the same period patient was treated with VISIPAQUE (View Visipaque Review and Visipaque Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), VERSED (MDAZOLAM HYDROCHLORIDE) (View Versed (mdazolam Hydrochloride) Review and Versed (mdazolam Hydrochloride) Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ). Patient was hospitalized.

6610120-9 | Coagulation Time Abnormal, Thrombosis In Device
on Mar 16, 2009 Male patient from UNITED STATES , 60 years of age, was diagnosed with percutaneous coronary intervention, stent placement and was treated with Angiomax (View Usage). Patient experienced the following unwanted or unexpected effects: coagulation time abnormal, thrombosis in device. Angiomax dosage: 0.75 Mg/kg, Bolus, Intravenous : 1.75 Mg/kg, Hr, Intravenous : 0.3 Mg/kg, Bolus, Intravenous. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ).

6610118-0 | Puncture Site Haemorrhage
on Mar 13, 2009 Female patient from UNITED STATES , 87 years of age, was diagnosed with percutaneous coronary intervention and was treated with Angiomax (View Usage). Patient had the following side effects: puncture site haemorrhage. Angiomax dosage: 12.8 Ml, Bolus, Intravenous : 17 Ml, Hr, Intravenous. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), LOVENOX (View Lovenox Review and Lovenox Label ).

6610094-0 | Coagulation Time Abnormal, Thrombosis In Device
Patient was taking Angiomax (View Usage). After Angiomax was administered, patient had the following side effects: coagulation time abnormal, thrombosis in device on Mar 10, 2009 from UNITED STATES Additional patient health information: Male patient , 73 years of age, was diagnosed with percutaneous coronary intervention, stent placement and. Angiomax dosage: 0.75 Mg/kg, Bolus, Intravenous; Altered Dose, Intervenous. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ).

6610079-4 | Blood Pressure Increased, Cerebral Haemorrhage, Disorientation, Headache, Subarachnoid Haemorrhage, Subdural Haemorrhage
Adverse event was reported on Mar 25, 2009 by a Male patient taking Angiomax (View Usage) (Dosage: 0.75 Mg/kg, Bolus, Intravenous; 1.75 Mg,hr, Intravenous) was diagnosed with percutaneous coronary intervention and. Location: UNITED STATES , 76 years of age, weighting 179.9 lb, Patient experienced the following unwanted or unexpected effects: blood pressure increased, cerebral haemorrhage, disorientation, headache (What is headache?), subarachnoid haemorrhage, subdural haemorrhage. During the same period patient was treated with PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), ASPIRIN (81 Mg, Qd; 162 M, Single) (View Aspirin Review and Aspirin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), BENICAR (View Benicar Review and Benicar Label ), ZOCOR (View Zocor Review and Zocor Label ), IMDUR (View Imdur Review and Imdur Label ), TRICOR /00499301/ (FENOFIBRATE) (View Tricor /00499301/ (fenofibrate) Review and Tricor /00499301/ (fenofibrate) Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ).

6610078-2 | International Normalised Ratio Increased
on May 07, 2009 Male patient from UNITED STATES , 50 years of age, weighting 172.0 lb, was diagnosed with percutaneous coronary intervention, stent placement and was treated with Angiomax (View Usage). Patient had the following side effects: international normalised ratio increased. Angiomax dosage: 0.75 Mg/kg, Bolus, Intravenous; 1.75 Mg/kg, Hr, Intravenous.

6610017-4 | International Normalised Ratio Increased
on Feb 17, 2009 Male patient from UNITED STATES , 64 years of age, weighting 269.0 lb, was diagnosed with percutaneous coronary intervention, stent placement and was treated with Angiomax (View Usage). After Angiomax was administered, patient had the following side effects: international normalised ratio increased. Angiomax dosage: 0.75 Mg/kg, Bolus, Intravenous. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

6610015-0 | Chest Pain, Thrombosis In Device, Underdose
Patient was taking Angiomax (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), thrombosis in device, underdose on Apr 14, 2009 from UNITED STATES Additional patient health information: Male patient , 76 years of age, weighting 170.0 lb, was diagnosed with percutaneous coronary intervention, stent placement and. Angiomax dosage: 11 Ml, Bolus, Intravenous, 26 Ml, Hr, Intravenous. During the same period patient was treated with FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), VERSED (View Versed Review and Versed Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ).

6609979-0 | Chest Pain, Thrombosis In Device
Adverse event was reported on Feb 03, 2009 by a Male patient taking Angiomax (View Usage) (Dosage: 0.75 Mg/kg, Bolus, Intravenous, 1.75 Mg/kg, Hr, Intravenous) was diagnosed with percutaneous coronary intervention and. Location: UNITED STATES , 50 years of age, Patient had the following side effects: chest pain (What is chest pain?), thrombosis in device. During the same period patient was treated with PLAVIX (600 Mg) (View Plavix Review and Plavix Label ). Patient was hospitalized.

6609919-4 | Chest Pain, Dyspnoea, Thrombosis In Device
on Feb 23, 2009 Female patient from UNITED STATES , 51 years of age, weighting 194.7 lb, was diagnosed with percutaneous coronary intervention and was treated with Angiomax (View Usage). After Angiomax was administered, patient had the following side effects: chest pain (What is chest pain?), dyspnoea, thrombosis in device. Angiomax dosage: 12.75 Ml, Bolus, , 29.9 Ml, Hr, 5 Mg/ml, Intravenous, 29.9 Ml, Hr, Intravenous. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), DILAUIDID (HYDROMORPHONE HYDROCHLORIDE) (View Dilauidid (hydromorphone Hydrochloride) Review and Dilauidid (hydromorphone Hydrochloride) Label ), INTEGRILIN (View Integrilin Review and Integrilin Label ), VERSED (View Versed Review and Versed Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

6609916-9 | Haemorrhage
on Jan 28, 2009 Female patient from UNITED STATES , 70 years of age, weighting 95.02 lb, was treated with Angiomax (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage. Angiomax dosage: Bolus, Intravenous, 2.3 Ml, Hr, Intravenous.

6609897-8 | Coagulation Time Abnormal, Gastrointestinal Haemorrhage
Patient was taking Angiomax (View Usage). Patient had the following side effects: coagulation time abnormal, gastrointestinal haemorrhage on Jan 14, 2009 from UNITED STATES Additional patient health information: Female patient , 82 years of age, was diagnosed with percutaneous coronary intervention and. Angiomax dosage: . During the same period patient was treated with INTEGRILIN (View Integrilin Review and Integrilin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ), PLAVIX (View Plavix Review and Plavix Label ).